654 related articles for article (PubMed ID: 8960666)
1. [Successful induction of immune tolerance and novel hemostatic effects in a hemophilia A with high-responder inhibitor by regular infusions of factor VIII].
Shima M; Sawamoto Y; Kamisue M; Shibata Y; Tuzi S; Kuwabara M; Tanaka I; Tanizawa T; Tanaka A; Ueda M; Kakishita E; Yoshioka A
Rinsho Ketsueki; 1996 Nov; 37(11):1303-8. PubMed ID: 8960666
[TBL] [Abstract][Full Text] [Related]
2. Successful immune tolerance induction with high-dose coagulation factor VIII and intravenous immunoglobulins in a patient with congenital hemophilia and high-titer inhibitor of coagulation factor VIII despite unfavorable prognosis for the therapy.
Kubisz P; Plamenová I; Hollý P; Stasko J
Med Sci Monit; 2009 Jun; 15(6):CS105-11. PubMed ID: 19488019
[TBL] [Abstract][Full Text] [Related]
3. [Suppression of factor VIII inhibitor in children with hemophilia A].
Zenz W; Muntean W
Padiatr Padol; 1987; 22(4):345-52. PubMed ID: 3125510
[TBL] [Abstract][Full Text] [Related]
4. Elective cardiac operation in a patient with severe hemophilia and acquired factor VIII antibodies.
Leggett PL; Doyle D; Smith WB; Culpepper W; Cooper S; Ochsner JL
J Thorac Cardiovasc Surg; 1984 Apr; 87(4):556-60. PubMed ID: 6423912
[TBL] [Abstract][Full Text] [Related]
5. Inhibitor antibodies to factor VIII and factor IX: management.
Lusher JM
Semin Thromb Hemost; 2000; 26(2):179-88. PubMed ID: 10919411
[TBL] [Abstract][Full Text] [Related]
6. New protocol for immune tolerance induction in acquired hemophilia.
Nemes L; Pitlik E
Haematologica; 2000 Oct; 85(10 Suppl):64-8. PubMed ID: 11187874
[TBL] [Abstract][Full Text] [Related]
7. Induction of immune tolerance in patients with hemophilia and antibodies to factor VIII by combined treatment with intravenous IgG, cyclophosphamide, and factor VIII.
Nilsson IM; Berntorp E; Zettervall O
N Engl J Med; 1988 Apr; 318(15):947-50. PubMed ID: 3127711
[TBL] [Abstract][Full Text] [Related]
8. Continuous high-dose factor VIII for the induction of immune tolerance in haemophilia A patients with high responder state: a description of eleven patients treated.
Scheibel E; Ingerslev J; Dalsgaard-Nielsen J; Stenbjerg S; Knudsen JB
Thromb Haemost; 1987 Dec; 58(4):1049-52. PubMed ID: 3127918
[TBL] [Abstract][Full Text] [Related]
9. Low-dose immune tolerance induction for paediatric haemophilia patients with factor VIII inhibitors.
Unuvar A; Kavakli K; Baytan B; Kazanci E; Sayli T; Oren H; Celkan T; Gursel T
Haemophilia; 2008 Mar; 14(2):315-22. PubMed ID: 18081830
[TBL] [Abstract][Full Text] [Related]
10. Treatment of anti-factor VIII antibodies.
Blatt PM; White GC; McMillan CW; Roberts HR
Thromb Haemost; 1977 Aug; 38(2):514-23. PubMed ID: 579493
[TBL] [Abstract][Full Text] [Related]
11. Rapid acquisition of immunologic tolerance to factor VIII and disappearance of anti-factor VIII IgG4 after prophylactic therapy in a hemophilia A patient with high-titer factor VIII inhibitor.
Moorehead PC; Thibeault L; Tuttle A; Grabell J; Dwyre L; Silva M; James P; Lillicrap D
J Pediatr Hematol Oncol; 2015 May; 37(4):e220-2. PubMed ID: 25411864
[TBL] [Abstract][Full Text] [Related]
12. [Factor VIII epitopes recognized by inhibitors in hemophiliacs].
Hayashi T; Niiya K; Sakuragawa N; Ichihara K; Yamazaki T; Watanabe A
Rinsho Ketsueki; 1991 Sep; 32(9):945-50. PubMed ID: 1719257
[TBL] [Abstract][Full Text] [Related]
13. Immune tolerance by intermittent factor VIII boluses in two high responder hemophilia A patients.
Landolfi R; de Cristofaro R; Lazzareschi I; Riccardi R; Mariani G
Haematologica; 2000 Oct; 85(10 Suppl):73-4. PubMed ID: 11187877
[TBL] [Abstract][Full Text] [Related]
14. Factor VIII inhibitors in patients with hemophilia A: epidemiology of inhibitor development and induction of immune tolerance for factor VIII.
Kreuz W; Becker S; Lenz E; Martinez-Saguer I; Escuriola-Ettingshausen C; Funk M; Ehrenforth S; Auerswald G; Kornhuber B
Semin Thromb Hemost; 1995; 21(4):382-9. PubMed ID: 8747701
[TBL] [Abstract][Full Text] [Related]
15. Immune tolerance induction and the treatment of hemophilia. Malmö protocol update.
Berntorp E; Astermark J; Carlborg E
Haematologica; 2000 Oct; 85(10 Suppl):48-50; discussion 50-1. PubMed ID: 11187871
[TBL] [Abstract][Full Text] [Related]
16. Inhibitors of factor VIII: detection and treatment.
Brettler DB
Southeast Asian J Trop Med Public Health; 1993; 24 Suppl 1():21-5. PubMed ID: 7886576
[TBL] [Abstract][Full Text] [Related]
17. [Preliminary experience with achieving immune tolerance in patients with hemophilia A and circulating factor VIII inhibitor].
Scharf R; Kucharski W; Lopaciuk S; Celińska W; Dmytrow A; Domański K; Gonet S; Miastkowski Z; Nowakowska I; Przybylski A
Acta Haematol Pol; 1991; 22(1):92-9. PubMed ID: 1823972
[TBL] [Abstract][Full Text] [Related]
18. [Recombinant activated Factor VII (Novoseven Novo Nordisk) for hemostasis in acquired Factor VIII-inhibitor hemophilia].
Meili EO; Dazzi H; von Felten A
Schweiz Med Wochenschr; 1995 Mar; 125(9):405-11. PubMed ID: 7892567
[TBL] [Abstract][Full Text] [Related]
19. Hemophilia. Strategies for the treatment of inhibitor patients.
Ingerslev J
Haematologica; 2000 Oct; 85(10 Suppl):15-20. PubMed ID: 11187863
[TBL] [Abstract][Full Text] [Related]
20. Incidence of factor VIII inhibitor development in hemophilia A patients treated with less pure plasma derived concentrates.
de Biasi R; Rocino A; Papa ML; Salerno E; Mastrullo L; De Blasi D
Thromb Haemost; 1994 May; 71(5):544-7. PubMed ID: 8091377
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
